A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis
Clinical trial NCT05516758 · TERMINATED
Trial details
- NCT number
- NCT05516758
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-31
- Primary completion
- 2023-11-20
- Enrollment
- 491
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.